Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The treatment landscape of occular melanoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.10.19
Views: 406

Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada

Maitry Patel speaks to ecancer at the APAO 2019 meeting in Boston about the treatment landscape of occular melanoma.

She states that plaque brachytherapy is most commonly used to treat this rare malignancy, along with enucleation if the tumour is large.

Patel also mentions some ongoing clinical trials that are exploring the use of systemic therapies, in the event of lung or liver metastasis. However, there is no evidence to suggest that this treatment is effective.

She emphasises the collaboration between radiation oncologists and the opthalmology team in the treatment of this disease type.

Patel concludes by discussing the importance and growth of physician associates (PAs) in this field.

Related videos

follow us

Biosimilar Medicines Core Principles and Communication

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation